IMUX
Immunic Inc.
Company Overview
| Mkt Cap | $83.36M | Price | $0.78 |
| Volume | 872.11K | Change | -0.69% |
| P/E Ratio | -0.8 | Open | $0.79 |
| Revenue | -- | Prev Close | $0.78 |
| Net Income | $-100.5M | 52W Range | $0.56 - $1.42 |
| Div Yield | N/A | Target | $6.35 |
| Overall | 33 | Value | 60 |
| Quality | 23 | Technical | 18 |
No chart data available
Stock Overview
Updated DailyImmunic Inc. (IMUX) is a leading Healthcare company in the Biotechnology industry, currently trading at $0.78 with a market capitalization of $83.36 million. The stock is in the lower portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 23.
Today's trading session shows IMUX with a volume of 872K shares. The stock opened up 0.74% from yesterday's close of $0.78. Current analyst estimates project earnings of $-0.71 per share for this year, with next year targeting $-0.43.
IMUX demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for IMUX include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 715.4%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 02:16 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | IMUX | $0.78 | -0.7% | 872.11K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |